The global corneal implants market is projected to grow at a CAGR of 6.4% during the forecast period. Increasing prevalence of ophthalmic disorders such as corneal vision loss along with rapidly growing geriatric population, rapid technologically advancements in optometry are factors driving the corneal implants market.
Adroit Market Research report on global corneal implants market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 and 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global corneal implants market have been studied in detail.
Corneal eye disease, which affects more than 10 million people worldwide, is the fourth most common cause of blindness after cataracts, glaucoma, and age-related macular degeneration. Thus, corneal implants are widely being adopted in order to treat patients with corneal eye diseases. Corneal implants offer several advantages such as improved vision, faster visual recovery, and lower risk of rejection which is expected to propel the growth of the market in the coming years. Furthermore, increase in preference for minimally invasive treatments, as well as growing awareness of corneal transplants will positively boost industry over the next few years. Increase in geriatric patient pool susceptible to ophthalmic disorders will further fuel the growth of the market in the future.
The global corneal implants market has been segmented based on type, transplant type, application, end-users, and region. Based on type, the global corneal implants market is categorized into human cornea and synthetic. Human cornea segment held substantial share of the market in 2019. On the basis of transplant type, the global corneal implants market is segmented into penetrating keratoplasty, and endothelial keratoplasty. Endothelial keratoplasty segment is anticipated to grow at a significant rate over the coming few years owing to benefits offered over penetrating keratoplasty. Moreover, increase in prevalence of Fuchs' dystrophy and other endothelial disorders of the cornea has made endothelial keratoplasty a preferred option for patients.
Application-wise, the global corneal implants market is segregated into Fuchs’ dystrophy, keratoconus, fungal keratitis, and others. Rapid rise in prevalence of Fuchs’ dystrophy along with growing awareness for early diagnosis will propel growth of the segment in the coming years. On the basis of end-users, the global corneal implants market is categorized into hospitals, specialty clinics, and ambulatory surgical centers. Hospitals accounted for majority of the market share in 2019.
North America dominated the global corneal implants market in 2019. High prevalence of corneal disorders leading to vision loss in the U.S. and Canada, and large number of corneal transplant procedures performed in the region are key factors likely to drive the growth of the market in the next few years. However, Asia Pacific corneal implants market is anticipated to grow at a rapid pace over the forecast period. Presence of large geriatric population, increase in disposable income, and high prevalence of corneal disorders will propel the global corneal implants in the region in the next few years.
Major players operating in the global corneal implants market include AJL Ophthalmic SA, Florida Lions Eye Bank, CorneaGen, San Diego Eye Bank, Alcon Inc., Aurolab, KeraMed, Inc., Massachusetts Eye and Ear, Alabama Eye Bank Inc., and DIOPTEX among others.
Key Segments of the Global Corneal Implants Market
Type Overview, 2018-2028 (USD Million)
- Human Cornea
Transplant Type Overview, 2018-2028 (USD Million)
- Penetrating Keratoplasty
- Endothelial Keratoplasty
Application Overview, 2018-2028 (USD Million)
- Fungal Keratitis
- Fuchs Dystrophy
End-users Overview, 2018-2028 (USD Million)
- Specialty Clinics
- Ambulatory Surgical Centers
Regional Overview, 2018-2028 (USD Million)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa